China Universal Asset Management Company’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,064
Closed -$49.2K 507
2025
Q2
$49.2K Buy
9,064
+26
+0.3% +$130 ﹤0.01% 421
2025
Q1
$31.4K Sell
9,038
-516
-5% -$2.5K ﹤0.01% 444
2024
Q4
$98.3K Buy
9,554
+1,650
+21% +$20.6K 0.01% 392
2024
Q3
$107K Buy
7,904
+3,092
+64% +$38.3K 0.01% 353
2024
Q2
$62.6K Sell
4,812
-2,972
-38% -$36.8K 0.01% 341
2024
Q1
$73.5K Buy
7,784
+3,119
+67% +$30.3K 0.01% 393
2023
Q4
$51.2K Buy
+4,665
New +$37K 0.01% 367

Other funds holding THRD

China Universal Asset Management Company's THRD Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 9,064 shares — an estimated $49.2K sold.

China Universal Asset Management Company first reported a position in THRD in Q4 2023 and held it in 7 quarters. The position peaked at $107K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • China Universal Asset Management Company reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 9,064 Third Harmonic Bio shares in Q3 2025, an estimated $49.2K.
  • China Universal Asset Management Company first reported a position in Third Harmonic Bio in Q4 2023 and held it in 7 quarters.
  • China Universal Asset Management Company's Third Harmonic Bio position peaked at $107K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.